SCHEMBL160269

SCHEMBL160269

CCCCCCC(CCCC)C(=O)O.CCCCCCC(CCCC)C(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.71
MAPK1 P28482 1/20 0.71
GRIK1 P39086 2/20 0.66
GRIK2 Q13002 2/20 0.66
SLC1A2 P43004 2/20 0.62
SLC1A1 P43005 2/20 0.62
GPR84 Q9NQS5 7/20 0.61
FFAR1 O14842 1/20 0.61
CHRM1 P11229 1/20 0.61
AKR1A1 P14550 1/20 0.61
CHRM3 P20309 1/20 0.61
HTR2A P28223 1/20 0.61
HTR2C P28335 1/20 0.61
ADRA1A P35348 1/20 0.61
HRH1 P35367 1/20 0.61
DRD3 P35462 1/20 0.61
SLC6A3 Q01959 1/20 0.61
HDAC1 Q13547 1/20 0.61
HDAC2 Q92769 1/20 0.61
TDP1 Q9NUW8 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1310131 1.00 CA2 (0.71) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL112082 1.00 CA2 (0.71) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL112564 1.00 CA2 (0.71) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL5683424 1.00 CA2 (0.71) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL9118821 1.00 CA2 (0.71) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL538817 1.00 CA2 (0.71) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL2492298 1.00 CA2 (0.71) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL1457282 1.00 CA2 (0.71) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL2836840 1.00 CA2 (0.71) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL3004163 1.00 CA2 (0.71) CA2MAPK1GRIK1GRIK2SLC1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 348 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4137118-A1 HAIR TREATMENT COMPOSITION COMPRISING TRIMETHYLGLYCINE BASED HAIR CONDITIONING AGENTS AND AN OIL Henkel AG & Co. KGaA (DE) 2023-02-22 EP claimed
EP-2934462-B1 TWO-PHASE DEVELOPER FOR OXIDATIVE COLOR CHANGING AGENTS HENKEL AG & CO KGAA (DE) 2017-11-29 EP claimed
EP-2413889-B1 WATER-FREE ANTIPERSPIRANT SPRAYS WITH IMPROVED ACTIVE SUBSTANCE RELEASE HENKEL AG & CO KGAA (DE) 2016-11-09 EP claimed
EP-2934462-A2 TWO-PHASE DEVELOPER FOR OXIDATIVE COLOR CHANGING AGENTS Henkel AG&Co. KGAA (DE) 2015-10-28 EP claimed
WO-2014095458-A2 TWO-PHASE DEVELOPER FOR OXIDATIVE COLOR CHANGING AGENTS HENKEL AG & CO. KGAA (DE) 2014-06-26 WO claimed
US-20140166035-A1 TWO PHASE DEVELOPER FOR MEDIUM OXIDATIVE COLOR CHANGE HENKEL AG & CO. KGAA (DE) 2014-06-19 US claimed
WO-2013144121-A2 ANTIPERSPIRANT COMPOUNDS COMPRISING CYCLOALIPHATIC DIOLS AND ZIRCONIUM SALTS HENKEL AG & CO. KGAA (DE) 2013-10-03 WO claimed
US-8354096-B2 Water-free antiperspirant sprays with improved substance HENKEL AG & CO. KGAA (DE) 2013-01-15 US claimed
EP-2413889-A2 WATER-FREE ANTIPERSPIRANT SPRAYS WITH IMPROVED SUBSTANCE RELEASE Henkel AG & Co. KGaA (DE) 2012-02-08 EP claimed
EP-2413890-A2 ANTIPERSPIRANT SPRAYS WITH ESTER OILS Henkel AG & Co. KGaA (DE) 2012-02-08 EP claimed
US-20120020906-A1 ANTIPERSPIRANT SPRAYS WITH ESTER OILS HENKEL AG & CO. KGAA (DE) 2012-01-26 US claimed
US-20120014897-A1 WATER-FREE ANTIPERSPIRANT SPRAYS WITH IMPROVED SUBSTANCE RELEASE HENKEL AG & CO. KGAA (DE) 2012-01-19 US claimed
WO-2010112459-A2 ANTIPERSPIRANT SPRAYS WITH ESTER OILS HENKEL AG & CO. KGAA (DE) 2010-10-07 WO claimed
WO-2010112460-A2 WATER-FREE ANTIPERSPIRANT SPRAYS WITH IMPROVED SUBSTANCE RELEASE HENKEL AG & CO. KGAA (DE) 2010-10-07 WO claimed
EP-1888012-A2 OIL-CONTAINING DEODORIZING AEROSOL COMPOSITIONS HAVING SKIN-COOLING ACTIVE SUBSTANCES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2008-02-20 EP claimed
WO-2006128622-A2 OIL-CONTAINING DEODORIZING AEROSOL COMPOSITIONS HAVING SKIN-COOLING ACTIVE SUBSTANCES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-12-07 WO claimed
EP-3723716-B1 KIT FOR PREPARING A BODY TREATMENT PRODUCT HENKEL AG & CO KGAA (DE) 2026-05-13 EP disclosed
EP-4731168-A1 OIL-IN-WATER EMULSION HAVING IMPROVED TEMPERATURE STABILITY, FOR OXIDATIVELY CHANGING THE COLOR OF KERATIN FIBERS Henkel AG & Co. KGaA (DE) 2026-04-29 EP disclosed
WO-1998017232-A1 COSMETIC AND SKIN CARE STICKS WITH HIGH WATER CONTENTS BEIERSDORF AG (DE) 1998-04-30 WO disclosed
WO-1998017238-A1 HIGHLY HYDRATED ANTI-PERSPIRANT AND/OR DEODORIZING STICKS BEIERSDORF AG (DE) 1998-04-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120020906-A1 ANTIPERSPIRANT SPRAYS WITH ESTER OILS CUTA, NAPEPLD, LIPE CA2 4825/4885MAPK1 3485/4885GRIK1 2329/4885
US-20120014897-A1 WATER-FREE ANTIPERSPIRANT SPRAYS WITH IMPROVED SUBSTANCE RELEASE POLR1C, CTRL, CUTA CA2 3560/4885MAPK1 3861/4885GRIK1 1412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.